WHO ICTRP trial
A multicentre study to assess the safety and efficacy of sodium hyaluronate…
EUCTR2005-002735-27-LV · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-002735-27-LV |
|---|---|
| Public title | A multicentre study to assess the safety and efficacy of sodium hyaluronate (Hyalgan-F) produced by fermentation in knee psteoarthritis. |
| Scientific title | A multicentre study to assess the safety and efficacy of sodium hyaluronate (Hyalgan-F) produced by fermentation in knee psteoarthritis. |
| Primary sponsor | Fidia Farmaceutici SpA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Latvia |
| Conditions | Knee oasteoarthritis |
| Interventions | Product Name: Hyalgan-F Product Code: Hyaluronan Pharmaceutical Form: Solution for injection INN or Proposed INN: Hyaluronic acid CAS Number: 6067-32-7 Current Sponsor code: Hyalgan-F Other descriptive name: Hyaluronan Concentration unit… |
| Registration date | Sep 23, 2005 |
| Target size | 120 |
| Secondary IDs | R30-05-01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: